View source for Rej 1993 Arch Pathol Lab Med

{{Publication
|title=Rej R  (1993) Accurate enzyme activity measurements: Two decades of development in the commutability of enzyme quality control materials. Arch Pathol Lab Med  117(4):352-64.
|info=[https://pubmed.ncbi.nlm.nih.gov/8466397/ PMID:8466397]
|authors=Rej R
|year=1993
|journal=Arch Pathol Lab Med
|abstract=Commercial serum preparations are integral components of both internal and external quality control programs for enzyme activity measurements. However, properties of these materials may differ significantly from those of clinical specimens. Differences from clinical specimens may include the following: species origin of the enzyme; isoenzyme form(s); integrity of the molecular species; matrix of the solution; processes such as lyophilization; and addition of preservatives. There are also significant differences among methods measuring the activity of a single enzyme including a diversity of compounds that may serve as substrate(s); variable cofactor or metal supplementation; and differences in the substrate concentration(s), buffer substances, pH, and temperature. The measured response to each of these variations in assay technique may differ among these types of specimens. To be acceptable, quality control materials must have properties similar to those of clinical specimens. Thus, the concept of commutability that we originated and first applied to enzyme activity measurements remains useful, and its further application to the problem of "matrix effects" is reviewed here. Multivariate display techniques are applied to the specific examples of aspartate aminotransferase, alpha-amylase, and alkaline phosphatase to judge the commutability of quality control materials for these enzymes.
|editor=[[Iglesias-Gonzalez J]]
}}
== Cited by ==
{{Template:Cited by Iglesias-Gonzalez 2021 MitoFit PT}}
{{Labeling
|additional=MitoFit 2021 PT
}}